Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:46 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | PERCEPTIVE ADVISORS LLC | 4,024,400 3.5% | -1,254,562 (-23.77%) | View |
| 2024-02-14 4:05 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 0 0% | -5,738,500 (Position Closed) | View |
| 2024-02-14 12:50 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | JANUS HENDERSON GROUP PLC JHG | 6,103,797 5.4% | 6,103,797 (New Position) | View |
| 2024-02-14 09:09 am Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | Avoro Capital Advisors LLC | 16,337,739 9.99% | 3,537,739 (+27.64%) | View |
| 2024-02-13 5:02 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | VANGUARD GROUP INC | 6,306,149 5.56% | 2,879,138 (+84.01%) | View |
| 2024-02-13 4:27 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover GP I LLC | 0 0% | -5,905,400 (Position Closed) | View |
| 2024-01-25 1:48 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | BlackRock Inc. BLK | 9,610,239 8.5% | 7,662,206 (+393.33%) | View |
| 2023-09-22 4:30 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | RA CAPITAL MANAGEMENT L.P. | 6,940,000 6.2% | 6,940,000 (New Position) | View |
| 2023-09-11 4:45 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,685,625 3.76% | 1,525,475 (+70.62%) | View |
| 2023-03-10 2:04 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | PERCEPTIVE ADVISORS LLC | 5,278,962 5.6% | 5,278,962 (New Position) | View |
| 2023-02-14 4:06 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 5,738,500 6.8% | 318,604 (+5.88%) | View |
| 2023-02-14 2:23 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover GP I LLC | 5,905,400 6.2% | 5,905,400 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | BlackRock Inc. BLK | 1,948,033 2.3% | -3,376,095 (-63.41%) | View |
| 2022-02-14 4:22 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | Boxer Capital LLC | 0 0% | -4,000,000 (Position Closed) | View |
| 2022-02-14 4:08 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 5,419,896 7.8% | 1,890,431 (+53.56%) | View |
| 2022-02-11 10:03 am Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | Avoro Capital Advisors LLC | 12,800,000 14.7% | 2,500,000 (+24.27%) | View |
| 2022-02-01 5:08 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | BlackRock Inc. BLK | 5,324,128 6.3% | -62,116 (-1.15%) | View |
| 2021-11-29 1:00 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover Management LLC | 5,905,400 7% | 5,905,400 (New Position) | View |
| 2021-07-12 2:44 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 3,529,465 5.1% | 3,529,465 (New Position) | View |
| 2021-02-16 4:04 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | D. E. SHAW & CO L.P. | 1,260,749 1.8% | -2,188,863 (-63.45%) | View |